CJC-1295 NO DAC + Ipamorelin (10mg Blend)
60.00€
Research Studies:
- Facilitates dual-receptor investigation of growth hormone secretagogue and GHRH signaling
- Supports analysis of pulsatile growth hormone secretion in controlled models
- Enables comparative modeling of somatotroph-specific cAMP and calcium flux
- Useful for evaluating synergistic ghrelin-mimetic and GHRH-analogous metabolic pathways
Blend Specification:
- CJC-1295 No Dac 5mg
- Ipamorelin 5mg
Description
CJC-1295 No DAC + Ipamorelin (10mg Blend)
CJC-1295 (No DAC) + Ipamorelin – Advanced GHRH & GHRP Peptide Stack
Contents: CJC-1295 (No DAC) + Ipamorelin Lyophilized Blend
Category: Research Peptide Combination
Administration: Subcutaneous injection (research use only)
This combination pairs CJC-1295 (No DAC), a Growth Hormone Releasing Hormone (GHRH) analog, with Ipamorelin, a Growth Hormone Releasing Peptide (GHRP). Together, they are widely studied for their synergistic effects on stimulating natural growth hormone secretion through complementary biological pathways.
CJC-1295 (No DAC) promotes pulsatile growth hormone release, while Ipamorelin selectively targets ghrelin receptors to enhance GH signaling. This dual mechanism is frequently explored in metabolic, recovery, and body composition research.
Key Features
- Dual-action GHRH + GHRP peptide combination
- Supports natural growth hormone secretion pathways
- Promotes recovery and tissue maintenance research
- Studied for body composition and metabolic balance
- Encourages physiological GH pulse activity
- Designed for synergistic peptide research protocols
How It Works
This peptide stack works through two complementary mechanisms that influence growth hormone release.
CJC-1295 (No DAC)
- Stimulates pituitary GH release in pulses
- Supports natural endocrine rhythm
- Enhances GH signaling pathways
Ipamorelin
- Activates ghrelin receptors selectively
- Supports GH secretion without broad hormonal impact
- Complements GHRH signaling activity
Synergistic Action
- Amplifies natural growth hormone pulsatility
- Supports metabolic and recovery-related research models
- Enhances overall GH pathway activation in studies
Why Choose This Stack?
The combination of CJC-1295 (No DAC) and Ipamorelin is widely used in research due to its synergistic mechanism, offering a balanced and targeted approach to growth hormone pathway stimulation compared to single-compound protocols.
Important Notice
This product is intended strictly for laboratory, educational, and research use only. Not for human consumption or therapeutic use. Proper laboratory handling and safety procedures are required.

Reviews
There are no reviews yet.